Koubek K
Folia Haematol Int Mag Klin Morphol Blutforsch. 1982;109(3):408-15.
Some sera from normal donors (1/18) and from leukaemic patients (2/7 with acute myeloid leukaemia [AML], 1/4 with chronic lymphatic leukaemia [CLL], 0/3 with acute lymphoblastic leukaemia [ALL]; with high numbers of leukaemic cells expressing Ia-like p28,33 antigen on the leukaemic cell surface) inhibited the complement mediated cytotoxic activity of highly specific xenogenous anti Ia-like sera (which were prepared by immunization of rabbits with insoluble membrane fractions of B-type lymphoid lines) at a titre 1:4 or less. This effect was not observed with antisera directed against other membrane marker determinants (e.g. T lymphocyte specific antigens). These results suggest that at least a small proportion of membrane bound Ia-like antigens can be released from cell surfaces and in some patients these Ia-like moieties are detectable (by sensitive inhibition assays) in the serum.
一些正常供体的血清(1/18)以及白血病患者的血清(7例急性髓细胞白血病[AML]中有2例,4例慢性淋巴细胞白血病[CLL]中有1例,3例急性淋巴细胞白血病[ALL]中无;白血病细胞表面有大量表达Ia样p28,33抗原的白血病细胞)以1:4或更低的滴度抑制了高特异性异种抗Ia样血清(通过用B型淋巴样细胞系的不溶性膜组分免疫兔子制备)的补体介导的细胞毒性活性。针对其他膜标记决定簇(如T淋巴细胞特异性抗原)的抗血清未观察到这种效应。这些结果表明,至少一小部分膜结合的Ia样抗原可以从细胞表面释放,并且在一些患者的血清中(通过灵敏的抑制试验)可以检测到这些Ia样部分。